Isaac Cheng

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Isaac Cheng

Earlier roles on record: Board Member at Amylyx Pharmaceuticals, Inc. (AMLX) until November 1, 2022. Amylyx Pharmaceuticals, Inc. reported in an 8-K filed November 2, 2022 that Isaac Cheng resigned as member of the board of directors, effective November 1, 2022.

“On November 1, 2022, Isaac Cheng, MD, a member of the board of directors of Amylyx Pharmaceuticals, Inc. (the "Company"), submitted his resignation from the board of directors, effective as of close of business on November 1, 2022.”

Amylyx Pharmaceuticals, Inc. Form 8-K, filed November 2, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Isaac Cheng's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Amylyx Pharmaceuticals, Inc. (AMLX)
Board Member

Proxy statement

Start not stated–2022-11-01

Company network

Recorded roles and call appearances connecting this person to public companies.

Amylyx Pharmaceuticals, Inc.

AMLX

Board Member

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Resigned: member of the board of directors Amylyx Pharmaceuticals, Inc. (AMLX)
2022-11-01